Skip to main content

Table 5 Basic modelling and patient information of papers included in systematic review

From: Prediction of resistance to chemotherapy in ovarian cancer: a systematic review

Study Patient prior chemotherapy treatment Model accounts for the different chemotherapies? Prognostic or predictive? Model validated?
Jeong et al. [22] Platinum-based Predictive
Lisowska et al. [23] Platinum/Cyclophosphamide, Platinum/Taxane Prognostic
Roque et al. [24] NS Prognostic
Li et al. [3] Platinum/Cyclophosphamide, Platinum/Taxane Prognostic
Schwede et al. [25] NS Prognostic
Verhaak et al. [26] NS Prognostic
Obermayr et al. [27] Platinum-based Prognostic
Han et al. [28] Platinum/Paclitaxel   Prognostic
Hsu et al. [29] Platinum/Paclitaxel    
  + additional treatments Prognostic
Lui et al. [30] NS Prognostic
Kang et al. [31] Platinum/Taxane   Prognostic
Gillet et al. [32] Carboplatin/Paclitaxel   Prognostic
Ferriss et al. [33] Platinum-based Predictive
Brun et al. [34] NS Prognostic
Skirnisdottir and Seidal [35] Carboplatin/Paclitaxel   Prognostic
Brenne et al. [36] NS Prognostic
Sabatier et al. [37] Platinum-based Prognostic
Gillet et al. [38] NS Prognostic
Chao et al. [39] NS Prognostic
Schlumbrecht et al. [40] Platinum/Taxane   Prognostic
Glaysher et al. [41] Platinum, Platinum/Paclitaxel Predictive
Yan et al. [42] Platinum-based Prognostic
Yoshihara et al. [43] Platinum/Taxane   Prognostic
Williams et al. [44] NS Predictive
Denkert et al. [45] Carboplatin/Paclitaxel   Prognostic
Matsumura et al. [46] Platinum-based Predictive
Crijns et al. [47] Platinum, Platinum/    
  Cyclophosphamide, Platinum/Paclitaxel Prognostic
Mendiola et al. [48] Platinum/Taxane   Prognostic
Gevaert et al. [49] NS Prognostic
Bachvarov et al. [50] Carboplatin/Paclitaxel,    
  Carboplatin/Cyclophosphamide, Cisplatin/Paclitaxel Prognostic
Netinatsunthorn et al. [51] Platinum/Cyclophosphamide   Prognostic
De Smet et al. [52] Platinum/Cyclophosphamide, Platinum/Paclitaxel Prognostic
Helleman et al. [53] Platinum/Cyclophosphamide, Platinum-based Prognostic
Spentzos et al. [54] Platinum/Taxane   Prognostic
Jazaeri et al. [55] Carboplatin/Paclitaxel, Cisplatin/Cyclophosphamide, Carboplatin/Docetaxel, Carboplatin Prognostic
Raspollini et al. [56] Cisplatin/Cyclophosphamide, Carboplatin/Cyclophosphamide, Carboplatin/Paclitaxel Prognostic
Hartmann et al. [57] Cisplatin/Paclitaxel, Carboplatin/Paclitaxel Prognostic
Spentzos et al. [58] Platinum/Taxane   Prognostic
Selvanayagam et al. [59] Cisplatin/Cyclophosphamide, Carboplatin/Cyclophosphamide, Cisplatin/Paclitaxel Prognostic
Iba et al. [60] Carboplatin/Paclitaxel   Prognostic
Kamazawa et al. [61] Carboplatin/Paclitaxel   Prognostic
Vogt et al. [62] Etoposide, Paclitaxel/Epirubicin, Carboplatin/Paclitaxel Predictive
  1. If more than one value is given, the study included patients treated with different treatments. NS: Not Specified.